We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

104 hedge funds and large institutions have $89.1M invested in Lineage Cell Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 24

1.3% less ownership

Funds ownership: 44.45%43.15% (-1.3%)

3% less funds holding

Funds holding: 107104 (-3)

16% less capital invested

Capital invested by funds: $107M → $89.1M (-$17.5M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

Holders
104
Holders Change
-3
Holders Change %
-2.8%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
6
Increased
26
Reduced
24
Closed
9
Calls
$64K
Puts
Net Calls
+$64K
Net Calls Change
+$16K